Reverse phase protein array is a high-throughput technology that performs protein assays on thousands of samples simultaneously, including tissue and cell lysates, serum, plasma or other body fluids.

Protein arrays are a relatively new technique for studying protein-protein interactions and profiling antibody binding and specificity, and in the past year a number of companies have released premade ...

Protein microarrays are emerging as one of the most active areas in biotechnology today. Steady advances are overcoming initial skepticism as to their feasibility and utility. Industry sources project ...

WEST LAFAYETTE, Ind. – A Purdue University biochemist has developed a novel method for detecting certain types of proteins that serve as indicators for cancer and other diseases. Glycoproteins are ...

SINGAPORE--(BUSINESS WIRE)--Sengenics, a functional proteomics company, today announced the product launch of a new KREX™-based array, the ImmuKyne™ protein array, in a bid to enhance and accelerate ...

Researchers in the laboratory of R. Graham Cooks at Purdue University have developed a mass spectrometry-based method of creating protein arrays. The technique, known as ion soft-landing, selects ...

Protein and peptide microarrays, the emerging tools for proteomics and clinical assays, are high-throughput methods that track binding events and activities, and decide the function of proteins on a ...

Microarrays provide a way of organizing biological samples for high-throughput analysis. Samples are arranged in columns and rows upon a support surface consisting of a glass slide, a nitrocellulose ...

What makes prions adopt toxic, self-perpetuating conformations? The question has baffled researchers for years. In the May 9 Nature online, Peter Tessier and Susan Lindquist from Boston’s Whitehead ...

Reverse phase protein array is a high-throughput technology that performs protein assays on thousands of samples simultaneously, including tissue and cell lysates, serum, plasma or other body fluids.

WEST LAFAYETTE, Ind. - A Purdue University biochemist has developed a novel method for detecting certain types of proteins that serve as indicators for cancer and other diseases. Glycoproteins are ...